Related Experiment Videos
[Clinical application of testing methods on acid-fast bacteria]
Satoshi Ichiyama1, Katsuhiro Suzuki
1Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto-shi, Kyoto 606-8507, Japan. sichiyam@kuhp.kyoto-u.ac.jp
Kekkaku : [Tuberculosis]
|June 1, 2005
Summary
Advances in clinical bacteriology for acid-fast bacteria, particularly tuberculosis, are driven by nucleic acid amplification tests (NAATs). Despite widespread use in Japan, clinicians need better understanding of new diagnostic methods for improved patient care.
Area of Science:
- Clinical microbiology and infectious diseases.
- Diagnostic advancements in acid-fast bacterial infections.
- Molecular diagnostics and epidemiology of tuberculosis.
Background:
- The past decade has seen significant progress in clinical bacteriology for acid-fast bacteria, largely due to DNA probe kits and nucleic acid amplification tests (NAATs).
- Japan leads global consumption of NAAT kits, yet a misconception exists among some clinicians that culture methods are unnecessary.
- Newer diagnostic techniques, including serodiagnosis and molecular epidemiology, are emerging but require enhanced clinical understanding and skill.
Framework:
- Smear microscopy with concentration methods and broth culture systems (e.g., MGIT) offer improved sensitivity and rapidity for tuberculosis diagnosis.
- Novel technologies for rapid anti-tuberculosis drug susceptibility testing (AST) utilize liquid culture and molecular detection of resistance genes (e.g., rpoB mutations).
- Nucleic acid amplification tests (NAATs) provide rapid identification of high-transmission risk tuberculosis cases, though limitations in sensitivity and viability differentiation persist.
Implementation:
- Pretreatment with NALC-NaOH simplifies bacterial collection, facilitating the adoption of collective smear methods and liquid media.
- Molecular biology techniques are increasingly applied for detecting drug resistance genes and for molecular epidemiology in routine laboratory work.
- Serodiagnostic kits for Mycobacterium avium complex (MAC) lung disease, detecting antibodies to glycolipids, are now covered by Japanese national health insurance.
Implications:
- Enhanced clinical skills in utilizing new diagnostic methods are crucial for advancing the clinical practice related to acid-fast bacteria in Japan.
- Accurate and timely diagnosis through improved microscopy, culture, and NAATs enables adequate treatment based on drug susceptibility testing.
- Molecular typing tools like IS6110 RFLP, Spoligotyping, and VNTR are valuable for tracking tuberculosis strains and understanding transmission dynamics.